Do you want to read an article? Please log in or register.
Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study
COPDLung Cancer
RECOMMENDED
Related content
RECOMMENDED
COPD
Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study
Am J Respir Crit Care Med.
Oelsner EC, Balte PP, Grams ME, Cassano PA, Jacobs DR, Barr RG, Burkart KM, Kalhan R, Kronmal R, Loehr LR, O'Connor GT, Schwartz JE, Shlipak M, Tracy RP, Tsai MY, White W, Yende S
doi: 10.1164/rccm.
COPDLung Cancer
Features of Chronic Obstructive Pulmonary Disease as Predictors of Lung Cancer
Chest.
Carr LL, Jacobson S, Lynch DA, Foreman MG, Flenaugh EL, Hersh CP, Sciurba FC, Wilson DO, Sieren JC, Mulhall P, Kim V, Kinsey CM, Bowler RP
doi: 10.1016/j.chest.2018.01.049.
COPD
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
Lancet Respir Med.
Gedebjerg A, Szépligeti SK, Wackerhausen LH, Horváth-Puhó E, Dahl R, Hansen JG, Sørensen HT, Nørgaard M, Lange P, Thomsen RW2
doi: 10.1016/
RECOMMENDED
Lung Cancer
Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study
Eur Respir J.
Raymakers AJN, Sadatsafavi M, Sin DD, FitzGerald JM, Marra CA, Lynd LD
doi: 10.1183/13993003.
COMMENTED
COPD
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS
Ann Am Thorac Soc.
Ghosh S, Anderson WH, Putcha N, Han MK, Curtis JL, Criner GJ, Dransfield MT, Barr RG, Krishnan JA, Lazarus SC, Cooper CB, Paine R 3rd, Peters SP, Hansel NN, Martinez FJ, Drummond MB, Current and former investigators of the SPIROMICS sites and reading centers
doi: 10.1513/AnnalsATS.201804-283OC.
Long-acting muscarinic antagonist and long-acting β2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery
Mol Clin Oncol.
Makino T, Otsuka H, Hata Y, Koezuka S, Azuma Y, Isobe K, Sugino K, Ebihara S, Homma S, Iyoda A
doi: 10.3892/mco.2018.1595.
RECOMMENDED
COPD
Accelerated epigenetic aging as a risk factor for chronic obstructive pulmonary disease and decreased lung function in two prospective cohort studies
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Aging (Albany NY).
Breen M, Nwanaji-Enwerem JC, Karrasch S, Flexeder C, Schulz H, Waldenberger M, Kunze S, Ollert M, Weidinger S, Colicino E, Gao X, Wang C, Shen J, Just AC, Vokonas P, Sparrow D, Hou L, Schwartz JD, Baccarelli AA, Peters A, Ward-Caviness CK
doi: 10.18632/aging.103784.
RECOMMENDED
AsthmaCOPDLung Cancer
Lung Cancer Risk Among Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Ann Am Thorac Soc
Charokopos A, Braman SS, Brown SAW, Mhango G, de-Torres JP, Zulueta JJ, Sharma S, Holguin F, Sigel KM, Powell CA, Federman AD, Wisnivesky JP
doi: 10.1513/AnnalsATS.202010-1280OC
RECOMMENDED
COPD
Prevalence, Symptom Burden and Under-Diagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Ann Am Thorac Soc.
Ruparel M, Quaife SL, Dickson JL, Horst C, Tisi S, Hall H, Taylor MN, Ahmed A, Shaw PJ, Burke S, Soo MJ, Nair A, Devaraj A, Sennett K, Hurst JR, Duffy SW, Navani N, Bhowmik A, Baldwin DR, Janes SM
doi: 10.1513/AnnalsATS.201911-857OC.